T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ralph Lauren
RL
$18.9B
| $180M | 0.02% |
929,169
-27,055
| -3% | -$5.25M |
|
452
Owens Corning
OC
$12.7B
| $178M | 0.02% |
1,008,058
+927,799
| +1,156% | +$164M |
|
453
Assurant
AIZ
$10.5B
| $178M | 0.02% |
893,137
-11,222
| -1% | -$2.23M |
|
454
Altria Group
MO
$111B
| $175M | 0.02% |
3,431,506
+314,985
| +10% | +$16.1M |
|
455
Vera Therapeutics
VERA
$1.55B
| $174M | 0.02% |
3,939,109
+318,974
| +9% | +$14.1M |
|
456
Cameco
CCJ
$34.9B
| $174M | 0.02% |
3,642,052
-1,433,712
| -28% | -$68.5M |
|
457
Zscaler
ZS
$43.6B
| $174M | 0.02% |
1,017,156
+359,730
| +55% | +$61.5M |
|
458
PNC Financial Services
PNC
$79.4B
| $173M | 0.02% |
933,785
-936,671
| -50% | -$173M |
|
459
TC Energy
TRP
$54B
| $172M | 0.02% |
3,614,870
+37,633
| +1% | +$1.79M |
|
460
Biohaven
BHVN
$1.48B
| $172M | 0.02% |
3,438,526
+154,047
| +5% | +$7.7M |
|
461
Main Street Capital
MAIN
$5.95B
| $171M | 0.02% |
3,412,553
-973
| -0% | -$48.8K |
|
462
Cardinal Health
CAH
$35.8B
| $171M | 0.02% |
1,545,541
-574,861
| -27% | -$63.5M |
|
463
Ultragenyx Pharmaceutical
RARE
$3.01B
| $170M | 0.02% |
3,068,654
+76,696
| +3% | +$4.26M |
|
464
Ionis Pharmaceuticals
IONS
$10.1B
| $169M | 0.02% |
4,210,172
+275,861
| +7% | +$11.1M |
|
|
MRO
465
DELISTED
Marathon Oil Corporation
MRO
| $168M | 0.02% |
6,314,059
+2,432,737
| +63% | +$64.8M |
|
466
ZTO Express
ZTO
$15.5B
| $167M | 0.02% |
6,757,871
-465,716
| -6% | -$11.5M |
|
467
Kohl's
KSS
$1.77B
| $167M | 0.02% |
7,930,905
-1,021,643
| -11% | -$21.6M |
|
468
Cytokinetics
CYTK
$6.08B
| $167M | 0.02% |
3,164,945
+806,602
| +34% | +$42.6M |
|
469
Huntington Ingalls Industries
HII
$10.7B
| $166M | 0.02% |
627,595
-273,443
| -30% | -$72.3M |
|
470
AerCap
AER
$21.5B
| $165M | 0.02% |
1,742,453
+10,978
| +0.6% | +$1.04M |
|
471
Quanta Services
PWR
$58.1B
| $164M | 0.02% |
549,677
+22,909
| +4% | +$6.83M |
|
472
Ameriprise Financial
AMP
$46.4B
| $163M | 0.02% |
347,526
+44,922
| +15% | +$21.1M |
|
473
Lamb Weston
LW
$7.7B
| $163M | 0.02% |
2,513,849
+2,313,317
| +1,154% | +$150M |
|
474
Pultegroup
PHM
$26.6B
| $162M | 0.02% |
1,125,914
+798,000
| +243% | +$115M |
|
475
KT
KT
$9.48B
| $160M | 0.02% |
10,431,174
+359,188
| +4% | +$5.52M |
|